BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 3872156)

  • 1. Clinical and serologic features of patients with polymyositis or dermatomyositis.
    Holden DJ; Brownell AK; Fritzler MJ
    Can Med Assoc J; 1985 Mar; 132(6):649-53. PubMed ID: 3872156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyositis/dermatomyositis: clinical features and outcome in 22 patients.
    Baron M; Small P
    J Rheumatol; 1985 Apr; 12(2):283-6. PubMed ID: 3875720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyositis-dermatomyositis--a 25-year follow-up of 50 patients (analysis of clinical symptoms and signs and results of laboratory tests).
    Chwalińska-Sadowska H; Małdykowa H
    Mater Med Pol; 1990; 22(3):205-12. PubMed ID: 2132428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis.
    Hanissian AS; Masi AT; Pitner SE; Cape CC; Medsger TA
    J Rheumatol; 1982; 9(3):390-4. PubMed ID: 7120234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis.
    Oddis CV; Medsger TA
    J Rheumatol; 1988; 15(5):807-11. PubMed ID: 3172094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [135 cases of polymyositis].
    Serratrice G; Schiano A; Pellissier JF; Pouget J
    Rev Neurol (Paris); 1986; 142(12):906-17. PubMed ID: 3563238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyositis-dermatomyositis:25 years of follow-up of 50 patients disease course, treatment, prognostic factors.
    Chwalińska-Sadowska H; Małdykowa H
    Mater Med Pol; 1990; 22(3):213-8. PubMed ID: 2132429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-developmental aspects in 44 cases of polymyositis/dermatomyositis].
    Bravaccio F; Tirri R; Ammendola A; Picillo U; Cantore R; Trabucco M; Tirri G
    Acta Neurol (Napoli); 1989; 11(2-3):102-16. PubMed ID: 2782112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the clinical picture and serologic profile in patients with dermatomyositis and polymyositis coexisting with neoplastic disease].
    Bobrowska-Snarska D; Ostanek L; Brzosko M
    Ann Acad Med Stetin; 2011; 57(2):32-8. PubMed ID: 23002666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous vasculitis in adult polymyositis/dermatomyositis.
    Feldman D; Hochberg MC; Zizic TM; Stevens MB
    J Rheumatol; 1983 Feb; 10(1):85-9. PubMed ID: 6842491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
    Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
    Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
    Leu CC; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary involvement in polymyositis and in dermatomyositis.
    Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B
    J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and misdiagnosis of anti-Jo-1 syndrome: analysis of 33 cases].
    Zheng WJ; Wei W; Tang FL
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1565-8. PubMed ID: 14642109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
    Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
    J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.